E.D.N.Y · No. 2:26-cv-05910
Full docket on CourtListener ↗
No federal docket timeline hydrated for this case yet (state-court settlements have no RECAP docket).
| Matter | Type | Practice area | Court | Date | Value |
|---|---|---|---|---|---|
| Unilever United States, Inc.source ↗ filed by Reese LLP · No. 2:26-cv-05910 · 28:1332 Diversity-Fraud · view case timeline → Comparable settlements $200M–$740M ▾No comparable ruling here directly addresses consumer product false-advertising claims against a CPG defendant; closest analog, Citizens of Humanity v. Donboli, shows courts scrutinizing 'Made in USA'-type labeling claims skeptically. Mixed outcomes across unrelated theories (MTD granted in part in Dougherty, reversed in Gelis) suggest high variance and no clear doctrinal alignment. Comparable settlements $200M–$740M median $274.75M · n=10 DiDi Global Inc. $740M · Merck & Co. Inc. a $688M · Toyota Industries $436M Per member (realized): ~$2,500 median · $2,500–$2,500 (n=1) Comparable verdict: Papaya $420M · Vital Pharmaceutical $293M Key precedent: Citizens of Humanity v. Donboli — nearest analog on consumer labeling claims, showing courts can find such suits lack probable cause/merit. Main risk: Claim dismissed for lack of materiality/reliance, as labeling suits often fail absent proof of deceptive intent (see Citizens of Humanity). This defendant: Unilever faces repeat false-advertising filings (Fitzgerald, Lisa, Edwards), suggesting recurring exposure to labeling/marketing claims. Rough EV model (wide — class size is the big unknown, not a prediction): $1M–$100M Single-case per-member benchmark (n=1) and absence of directly on-point false-advertising rulings make this estimate highly speculative. · grounded in 10 rulings, 10 settlements, 9 verdicts | Filing | False Advertising | E.D.N.Y | 2026-09-23 | $200M–$740M comparable settlements |